Hapbee (HAPB): The Netflix of Feelings
After 15 years, $70 million spent on R&D, and 350,000+ hours of testing, this "Netflix of Feelings" wearable technology is finally hitting the consumer...
Aphex BioCleanse Systems (SNST) Signs European Supply and Private Label Agreement for DermAphex® and...
PITTSFORD, N.Y. , Dec. 16, 2020 /PRNewswire/ -- Aphex BioCleanse Systems, Inc. (OTCPK: SNST) ("Aphex" or "the Company") , a sanitization solutions company focused on the development and distribution of chemical-free,...
Mitesco (MITI) Expands ‘The Good Clinic’ to Colorado.
Mitesco Expands Footprint for The Good Clinic to Colorado at Lennar Multi-Family Developments to Serve as Stepping Stone to National Presence
MINNEAPOLIS, MN, Dec. 15,...
Scott Donnell Used His Intuition to Launch Hapbee (HAPB). Video.
My next guest, Scott Donnell, who is a serial entrepreneur and CEO of Hapbee (www.hapbee.com), had a knack for business early in life.
LIVE QUOTE
RELATED:...
BioSig (BSGM) Achieves First Commercial Sale of Three PURE EP Systems
Sale Marks Milestone for Company's Commercial expansion at leading Center of Excellence
Westport, CT, Dec. 11, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM)...
SinoFresh. One-Stop E-Commerce OTC Health & Wellness Pharmacy
https://youtu.be/axnge8NPH1s
https://vimeo.com/463146147
Adding Hepion Pharma (HEPA) $1.73 to Watch List.
Adding Hepion Pharma ($1.73) to Watch List. Oh My. What Did We Find Here?
Oh my…and Oh boy. We just signed a new client and...
Newsletter: Institutional Analyst. And Yes, We Have Another Double.
1. Dalrada (DFCO) $0.19. And Yes, We Have Another Double!2. Dyadic (DYAI) $6.40. We're Up 392%, Video Presentation.3. BioSig (BSGM) $4.70. We're Up 60%,...
Dalrada (DFCO) Appoints Gregory L. Remsen To Vice President of Strategic Relationships.
Dalrada Financial Corporation Appoints Gregory L. Remsen To Vice President of Strategic Relationships
DALRADA NEWS ARCHIVE
SAN DIEGO , Dec. 8, 2020 /PRNewswire/ -- Dalrada Financial Corp. (OTC Pink: DFCO) announces...
Committed to Win. C-1 and Dyadic’s (DYAI) Drive to Make Vaccines Affordable Worldwide.
Dyadic International, Inc. (NASDAQ: DYAI) – We are a global biotechnology company focused on further improving and leveraging the patented and proprietary C1 expression...















